Fate Therapeutics, Inc. (FATE)
NASDAQ: FATE · Real-Time Price · USD
2.775
-0.025 (-0.89%)
Aug 10, 2026, 12:31 PM EDT - Market open
Fate Therapeutics Market Cap
Fate Therapeutics has a market cap or net worth of $323.45 million as of August 10, 2026. Its market cap has increased by 206.30% in one year.
Market Cap
323.45M
Enterprise Value
225.41M
1-Year Change
206.30%
Ranking
Category
Stock Price
$2.78
ChartMarket Cap Chart
Since October 1, 2013, Fate Therapeutics's market cap has increased from $126.10M to $323.45M, an increase of 156.50%. That is a compound annual growth rate of 7.60%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 10, 2026 | 323.45M | 185.23% |
| Dec 31, 2025 | 113.40M | -39.65% |
| Dec 31, 2024 | 187.90M | -49.05% |
| Dec 29, 2023 | 368.80M | -62.38% |
| Dec 30, 2022 | 980.40M | -82.45% |
| Dec 31, 2021 | 5.59B | -29.57% |
| Dec 31, 2020 | 7.93B | 436.27% |
| Dec 31, 2019 | 1.48B | 78.70% |
| Dec 31, 2018 | 827.80M | 225.01% |
| Dec 29, 2017 | 254.70M | 197.20% |
| Dec 30, 2016 | 85.70M | -11.47% |
| Dec 31, 2015 | 96.80M | -6.47% |
| Dec 31, 2014 | 103.50M | -19.01% |
| Dec 31, 2013 | 127.80M | 1.35% |
| Oct 1, 2013 | 126.10M | - |
View and export this data all the way back to 2013. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Vicore Pharma Holding AB | 340.42M |
| Clinuvel Pharmaceuticals | 336.21M |
| Agenus | 311.48M |
| Turn Therapeutics | 310.09M |
| Anavex Life Sciences | 309.52M |
| Opus Genetics | 302.49M |
| Vanda Pharmaceuticals | 302.31M |
| Neumora Therapeutics | 302.01M |